Description

[1,2,5]Oxadiazolo[3,4-B]Pyrazine,4,5,6,7-Tetrahydro-4,7-Dimethyl-,1-Oxide(9Ci) is a specialized heterocyclic compound belonging to the fused oxadiazolopyrazine class, valued for its unique structural framework. This compound serves as a versatile and high-value chemical intermediate and research building block for advanced material and pharmaceutical development. It is primarily sought by R&D chemists and process development teams in the pharmaceutical, agrochemical, and material science industries for synthesizing novel molecules with targeted properties.

Application

• Pharmaceutical Intermediate: A key precursor in the synthesis of novel drug candidates, particularly in central nervous system (CNS) and oncology research.
• Agrochemical Research: Used in the development of new herbicides, fungicides, and insecticides with novel modes of action.
• Material Science: Serves as a building block for creating advanced organic electronic materials, such as charge-transport layers or light-emitting components.
• Energetic Materials Research: Investigated as a potential component in the design of high-energy-density materials (HEDMs) due to its nitrogen-rich, fused-ring structure.
• Ligand Synthesis: Utilized in organometallic chemistry for the preparation of complex ligands used in catalysis.
• Academic & Contract Research: A valuable tool for synthetic organic chemists in universities and CROs exploring new heterocyclic chemistry and reaction methodologies.

Basic Information

Product Name	[1,2,5]Oxadiazolo[3,4-B]Pyrazine,4,5,6,7-Tetrahydro-4,7-Dimethyl-,1-Oxide(9Ci)
CAS No.	98778-10-0
Molecular Formula	C7H10N4O2
Molecular Weight	182.18 g/mol
Synonyms	4,5,6,7-Tetrahydro-4,7-dimethyl-[1,2,5]oxadiazolo[3,4-b]pyrazine 1-oxide; 4,7-Dimethyl-4,5,6,7-tetrahydro-[1,2,5]oxadiazolo[3,4-b]pyrazine 1-oxide; 4,7-Dimethyl-4,5,6,7-tetrahydro[1,2,5]oxadiazolo[3,4-b]pyrazine 1-oxide; Fused oxadiazolopyrazine derivative; 1-Oxido-4,7-dimethyl-4,5,6,7-tetrahydro[1,2,5]oxadiazolo[3,4-b]pyrazine
EINECS	Contact for details

Quality Control

Every batch of [1,2,5]Oxadiazolo[3,4-B]Pyrazine,4,5,6,7-Tetrahydro-4,7-Dimethyl-,1-Oxide(9Ci) is manufactured under controlled conditions and undergoes rigorous analytical testing to ensure identity, purity, and consistency. Our quality management system is designed to meet the stringent requirements of research and development and pre-clinical manufacturing. Comprehensive Certificates of Analysis (COA) detailing purity, assay, and impurity profiles are provided with each shipment to support your quality assurance protocols.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at a controlled room temperature (15-25°C). Due to its hygroscopic nature, the container must be kept tightly sealed after opening to minimize exposure to atmospheric moisture. For long-term storage, consider using desiccants.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to reference spectrum
Assay (HPLC)	≥ 97.0%
Water Content (KF)	≤ 1.0%
Residue on Ignition	≤ 0.1%
Related Substances (HPLC)	Total impurities ≤ 2.0% Any single impurity ≤ 0.5%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.